Zacks Company Profile for Cardiovascular Systems, Inc. (CSII : NSDQ) |
|
|
|
Company Description |
Cardiovascular Systems, Inc. is a medical device manufacturer that develops and commercializes innovative solutions to treat patients suffering from peripheral and coronary arterial diseases, including those with arterial calcium. The foundation of the company's business is catheter-based platforms, which are capable of treating a wide spectrum of vessel sizes and plaque types. The company sells its products through direct sales force in the United States. The company delivers a unique, patented Orbital Atherectomy System of products that remove calcified and fibrotic plaque in arterial vessels throughout the leg and heart in very short treatment time. These products address many of the limitations associated with standard surgical, catheter and pharmacological treatment alternatives. The company is investing in sales, marketing, medical education, clinical studies and product research and development for its next phase of growth in the peripheral market and continue the commercialization of its CAD System.
Number of Employees: 780 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $15.94 |
Daily Weekly Monthly
 |
20 Day Moving Average: 361,454 shares |
Shares Outstanding: 40.78 (millions) |
Market Capitalization: $650.11 (millions) |
Beta: 0.91 |
52 Week High: $44.57 |
52 Week Low: $14.12 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-25.96% |
-19.18% |
12 Week |
-15.30% |
-8.46% |
Year To Date |
-15.12% |
0.53% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Scott R. Ward - Chief Executive Officer; Chairman and President
Jeffrey S. Points - Chief Financial Officer
Martha Goldberg Aronson - Director
Edward Brown - Director
William E. Cohn - Director
|
|
Peer Information
Cardiovascular Systems, Inc. (BJCT)
Cardiovascular Systems, Inc. (CADMQ)
Cardiovascular Systems, Inc. (APNO)
Cardiovascular Systems, Inc. (UPDC)
Cardiovascular Systems, Inc. (IMTIQ)
Cardiovascular Systems, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 141619106
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
|
|
Share - Related Items
Shares Outstanding: 40.78
Most Recent Split Date: 2.00 (0.10:1)
Beta: 0.91
Market Capitalization: $650.11 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $-0.22 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-0.91 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 6.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: 8.07% |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/03/22 |
|
|
|
|